Skip to main content
. 2022 Sep 30;3(1):100228. doi: 10.1016/j.xops.2022.100228

Table 3.

Performance Characteristics (Sensitivity, Specificity, and Imageability/Gradability) for Subject Eyes with Dilated Ophthalmoscopy Examinations at Nonretina Sites (N = 778), Retina Sites (N = 221), and Total (N = 999)

Cohort (No. of Eyes with CRS) Screening Methodology Sensitivity (95% CI) Specificity (95% CI) Imageability/Gradability (95% CI)
Subjects with dilated ophthalmoscopy (n = 999 eyes) Dilated ophthalmoscopy 27.7% [20.1%–35.2%] 99.6% [99.1%– 100.0%] 99.9% [99.7%–100.0%]
EyeArt system (with dilation-if-needed)
(147 eyes dilated)
96.4% [93.1%–99.8%] 88.4% [85.8%–91.1%] 97.4% [96.0%–98.8%]
Subjects enrolled at nonretina specialty centers (n = 778 eyes) Dilated ophthalmoscopy 20.6% [13.1%–28.0%] 99.8% [99.5%–100.0%] 99.9% [99.6%–100.0%]
EyeArt system (with dilation-if-needed)
(109 eyes dilated)
96.5% [92.9%–100.0%] 86.3% [83.0%–89.7%] 97.6% [96.0%–99.1%]
Subjects enrolled at retina specialty centers (n = 221 eyes) Dilated ophthalmoscopy 59.5% [40.2%–78.7%] 98.9% [97.1%– 100.0%] 100.0% [100.0%–100.0%]
EyeArt system (with dilation-if-needed)
(38 eyes dilated)
97.3% [90.3%–100.0%] 88.0% [82.5%–93.5%] 96.8% [93.6%–100.0%]

CI = confidence interval; CRS = clinical reference standard (as per reading center).